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Abstract
Bile duct injury (BDI) is a dangerous complication of cholecystectomy, with significant postoperative sequelae for
the patient in terms of morbidity, mortality, and long-term quality of life. BDIs have an estimated incidence of 0.4–
1.5%, but considering the number of cholecystectomies performed worldwide, mostly by laparoscopy, surgeons
must be prepared to manage this surgical challenge. Most BDIs are recognized either during the procedure or in
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the immediate postoperative period. However, some BDIs may be discovered later during the postoperative period,
and this may translate to delayed or inappropriate treatments. Providing a specific diagnosis and a precise
description of the BDI will expedite the decision-making process and increase the chance of treatment success.
Subsequently, the choice and timing of the appropriate reconstructive strategy have a critical role in long-term
prognosis. Currently, a wide spectrum of multidisciplinary interventions with different degrees of invasiveness is
indicated for BDI management. These World Society of Emergency Surgery (WSES) guidelines have been produced
following an exhaustive review of the current literature and an international expert panel discussion with the aim of
providing evidence-based recommendations to facilitate and standardize the detection and management of BDIs
during cholecystectomy. In particular, the 2020 WSES guidelines cover the following key aspects: (1) strategies to
minimize the risk of BDI during cholecystectomy; (2) BDI rates in general surgery units and review of surgical
practice; (3) how to classify, stage, and report BDI once detected; (4) how to manage an intraoperatively detected
BDI; (5) indications for antibiotic treatment; (6) indications for clinical, biochemical, and imaging investigations for
suspected BDI; and (7) how to manage a postoperatively detected BDI.
Keywords: Laparoscopic cholecystectomy, Biliary duct injury, Magnetic resonance imaging, Antibiotic therapy,
Computed tomography, Guidelines
Background
The World Society of Emergency Surgery (WSES) was
founded in 2007 with the mission of promoting training
and continuing medical education in emergency general
surgery and trauma. Since its establishment, the WSES
has launched and curated several clinical guidelines for
specific topics related to emergency and trauma surgery,
which are regularly updated to provide evidence-based
guidance to emergency surgeons in their daily practice
[1–3]. From this perspective, the present manuscript de-
scribes the international work conducted by WSES
members to build consensus guidelines for the detection
and management of one of the most severe complica-
tions of cholecystectomy, namely, bile duct injury (BDI).
Laparoscopic cholecystectomy (LC) is the gold stand-
ard operation for patients with gallstone disease and rep-
resents one of the most common routine interventions
performed worldwide in both elective and emergency
settings [4, 5]. Bile duct injuries (BDIs) are dangerous
complications of cholecystectomy, occurring more
often since the introduction and widespread adoption
of laparoscopy (0.4–1.5% of cases) compared to open
cholecystectomy (0.2–0.3% of cases) [4, 6–9]. Since
early reports, the frequency of BDIs during LC has
been progressively decreasing. However, the injuries
seen currently tend to be more severe, with the most
severe biliary and hepatic artery or portal vein injuries
often occurring after conversion from laparoscopy to
open cholecystectomy [5, 10].
BDIs are a surgical challenge associated with signifi-
cant postoperative sequelae for the patient in terms of
morbidity, mortality (up to 3.5%), and long-term quality
of life [11–13]. Injuries of the bile duct system occurring
during cholecystectomy are complex and require prompt
identification and management. Visualization of BDIs
might be hindered by accompanying vascular injuries,
particularly in the branches of the right hepatic artery.
Failed attempts to repair BDIs can result in longitudinal
strictures of the common bile duct [7, 11, 14–16]. Most
BDIs are recognized either during the procedure or in
the immediate postoperative period, with the two most
frequent scenarios being the occurrence of a bile leak or
bile duct obstruction [11, 17]. However, some BDIs may
be discovered later in the postoperative period, and this
often translates to delayed or inappropriate treatments,
especially when BDI patients need to be referred from a
secondary hospital to a tertiary care center for definitive
management. Providing a specific diagnosis and a pre-
cise description of the BDI facilitates the decision-
making process and increases the chance of treatment
success [9, 18]. In delayed cases, the choice and timing
of the appropriate reconstructive procedure have a crit-
ical role in long-term prognosis.
Currently, there is a wide spectrum of interventions
used in the management of BDI with different degrees
of invasiveness, ranging from computed tomography
(CT)-guided drainage to various endoscopic and surgical
techniques. With such a variety of interdisciplinary op-
tions available and the need to act promptly, close co-
operation between gastroenterologists, radiologists, and
surgeons is of upmost importance [4, 9, 17–20].
The present WSES guidelines aim to facilitate efficient
interdisciplinary cooperation, providing evidence-based
recommendations for the prevention, detection, and
management of BDIs during cholecystectomy. The
process was initiated in April 2019 and was structured
around 7 key questions that were addressed by compre-
hensive literature reviews conducted by 7 groups of
international multidisciplinary experts. The worldwide
participation in these WSES guidelines was deemed es-
sential to capture the experience and practice of differ-
ent realities in multiple countries, beyond the evidence
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in the literature, and to ultimately propose clinical
guidelines that can contribute to standardizing BDI
treatments and research objectives in the future. The
present guidelines apply for all cholecystectomy-related
BDI regardless of the surgical approach. However, being
LC the gold standard with the great majority of the
literature referring to this procedure, it will be the
most frequently considered in the following
recommendations.
Guideline scope and methods
In April 2019, the President and the scientific committee
of the WSES appointed three experts (Fausto Catena,
Nicola de’Angelis, and Daniele Sommacale) to establish
the project committee and determine the organization of
an international multidisciplinary expert panel to de-
velop the WSES Guidelines for the detection and man-
agement of BDIs. Briefly, the development of the WSES
guidelines was structured in two steps: a synthesis of the
current literature and a consensus conference held
during the 7th WSES World Congress.
In the first step, the project committee identified 7 key
questions regarding BDIs to be addressed by a thorough
analysis of the available literature. Seven groups of ex-
perts, including surgeons, anesthesiologists, gastroenter-
ologists, hepatologists, and radiologists, were identified
(Table 1). For each working group, a leader and co-
leader(s) were designated as responsible for coordinating
the work of the group’s experts and providing a
summary document that aligned the group’s
recommendations.
The literature evaluation was conducted by performing
bibliographic searches related to the 7 key questions
using a systematic approach and exploring different
electronic databases, including PubMed and EMBASE.
There was no date or language restriction. Within each
Table 1 The 7 key questions and the working groups of experts who contributed to the WSES guidelines on biliary duct injury (BDI)
detection and management
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group, a scientific discussion ensued via email and/or
videoconference and a synthesis document based on lit-
erature evidence, clinical experience, and expert discus-
sion were developed. Experts were instructed to
formulate statements and recommendations, as they did
for previous WSES guidelines [2, 21, 22], and assess the
level of evidence and the strength of the recommenda-
tions according to the AGREE II requirements and
adopting the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) criteria (https://
www.gradeworkinggroup.org/) [23, 24]. The quality of
evidence was graded as “High,” “Moderate,” “Low,” or
“Very low,” whereas the strength of a recommendation
was indicated as either “Strong” or “Weak.” Statements
and recommendations were reviewed by the project
committee to create a comprehensive draft version of
the guidelines, including all 7 key questions to be avail-
able prior to the consensus conference.
The consensus conference was planned during the 7th
WSES World Congress that was initially scheduled to
take place in Milano in June 2020. Due to the COVID-
19 pandemic, the event was rescheduled to occur on the
16th–19th of November 2020 using a virtual format. Dur-
ing the conference, a representative of the project com-
mittee presented the summary documents of the
working groups and detailed the statements and recom-
mendations, the supporting literature, and the level and
strength of the supporting evidence.
The revised statements, their level of evidence, and
their recommendation grades are presented below.
Please note that the WSES guidelines must be consid-
ered as an adjunctive tool in the decision-making
process regarding the management of BDIs; they are not
intended to substitute a provider’s clinical judgment re-
garding an individual patient or specific clinical situ-
ation, and they may need to be adapted to be consistent
with the medical team’s experience and the available
local resources.
BDI key questions
Q1. What are the general recommendations to minimize the risk of
BDI during laparoscopic cholecystectomy in elective and
emergency settings?
Statements:
1.1. The use of the CVS during LC (achieving all 3 components) is the
recommended approach to minimize the risk of BDIs.
Strong recommendation, low quality of evidence (GRADE 1C)
1.2. If the CVS is not achievable during a difficult LC, a bailout
procedure, such as STC, should be considered.
Strong recommendation, moderate quality of evidence (GRADE 1B)
1.3. Conversion to open surgery may be considered during a difficult LC
whenever the operating surgeon cannot manage the procedure
laparoscopically. However, there is insufficient evidence to support
conversion to open surgery as a strategy to avoid or reduce the risk of
BDI in difficult LCs.
BDI key questions (Continued)
Weak recommendation, moderate quality of evidence (GRADE 2B)
1.4. Intraoperative IOC is useful to recognize bile duct anatomy and
choledocholithiasis in cases of intraoperative suspicion of BDI,
misunderstanding of biliary anatomy, or inability to see the CVS, but
routine use to reduce the BDI rate is not yet recommended.
Weak recommendation, high quality of evidence (GRADE 2A)
1.5. Intraoperative ICG-C is a promising noninvasive tool to recognize
bile duct anatomy and vascular structures, but routine use to reduce the
BDI rate is not yet recommended.
Weak recommendation, low quality of evidence (GRADE 2C).
1.6. In patients presenting with AC, the optimal timing for
cholecystectomy is within 48 h, and no more than 10 days from
symptom appearance.
Strong recommendation, good quality of evidence (GRADE 1A)
1.7. In patients with at-risk conditions (e.g., scleroatrophic cholecystitis,
Mirizzi syndrome), an exhaustive preoperative work-up prior cholecystec-
tomy is mandatory in order to discuss and balance the risks/benefits ra-
tio of the procedure.
Weak recommendation, low quality of evidence (GRADE 2C)
Literature review
Due to the potentially severe consequences of BDIs, all
efforts should be made to minimize the risk of
occurrence in both elective and emergency
cholecystectomies. Optimal strategies for the prevention
of BDI include technical and procedural considerations
that must be adapted based on anatomical factors, the
patient’s clinical status, disease factors, and the surgeon’s
experience [5]. An exhaustive preoperative work-up
prior to cholecystectomy is mandatory in order to detect
at-risk conditions (e.g., scleroatrophic cholecystitis, Mir-
izzi syndrome [25–27]), choose the best surgical ap-
proach, and discuss the risks/benefits ratio of the
procedure.
Critical view of safety
LC is the preferable approach also for AC and is
associated with lower mortality and morbidity rates [28–
34]. The risk of conversion to open surgery appears to
be higher with male sex, age > 60 years, obesity,
cirrhosis, previous upper abdominal surgery, presence of
comorbidity, large bile stones, fever, elevated serum
bilirubin levels, gangrenous cholecystitis, severe acute,
and chronic cholecystitis, contracted gallbladder on
imaging, duration of complaints > 48 h, and emergency
LC [35–37]. Conversion to open surgery may be
considered for patient safety if the operating surgeon
cannot manage a difficult LC; however, there is no
evidence to support that conversion to open per se will
avoid or reduce the risk of BDI [5, 38, 39]. The critical
view of safety (CVS) technique was introduced in 1995
to guarantee the safest approach to LC by promoting the
recognition of gallbladder elements, particularly the
hepatocystic triangle (composed of the cystic duct,
common bile duct, and liver) [40, 41], a crucial step to
reduce the risk of BDI associated with mistakes in visual
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perception. The literature has demonstrated that when
the CVS is identified, the risk of iatrogenic
intraoperative complications is minimized [42–44].
Thus, routine use of CVS is recommended over other
techniques, such as the infundibular approach [5, 42, 45,
46]. However, achieving a complete CVS is easily
obtained in only 50% of cases. The component most
commonly incomplete is clearance of the lower third of
the gallbladder from the liver bed, and CVS cannot
always be applied if the hepatocystic angle is affected by
advanced inflammation or contracting fibrosis due to
preceding episodes of inflammation.
It has been reported that injuries of the common bile
duct are more common during the early learning curve
in laparoscopic cholecystectomy [47]. Thus, the use of
CVS could be of greater importance for trainees and
residents; in this scenario, the trainee or resident must
secure the CVS, and the supervising surgeon must
confirm the CVS before the cystic duct and cystic artery
are ligated.
Bailout procedures
Whenever a CVS cannot be achieved and the biliary
anatomy cannot be clearly defined, alternative techniques
such as the “fundus-first (top-down)” approach or subtotal
cholecystectomy (STC) should be considered [5, 48].
Several studies have shown how the “fundus-first”
technique is associated with reduced rates conversion rate
and iatrogenic complications (including BDIs) during
difficult operations, such as in cases of severe AC [49–52],
although the risk of vascular and biliary injuries cannot be
completely eliminated [10, 53]. It is essential to recognize
approaching areas of danger during LC and, in response,
stop dissection and change to a bailout procedure (STC or
cholecystostomy) to minimize the need for conversion
and to reduce the risk of BDI [48, 54–56]. However, STC
is associated with significantly more surgical site
infections, a need for re-interventions, and a longer hos-
pital stay than total cholecystectomy [57]. STC showed ad-
vantages over a converted cholecystectomy in which
conversion will not solve the difficulty of an inflamed
hepatocystic triangle [58].
Intraoperative biliary imaging
Intraoperative cholangiography (IOC) is an imaging
technique that may be used during LC to recognize
choledocholithiasis and define the biliary anatomy [59].
However, its routine use is not currently advisable since
it is not associated with a significant reduction in rates
of complications and BDIs during LC [60, 61]. Indeed,
BDI may also occur after IOC because of
misinterpretation of the IOC findings. IOC may be
recommended in cases of intraoperative suspicion of
BDI, misunderstanding of the biliary anatomy, or even
inability to see the CVS, as well as in patients with AC
or a history of AC, for whom intraoperative imaging,
although associated with longer operative time, could be
of greatest benefit [5]. Importantly, identification of a
BDI using IOC can lead to earlier diagnosis and
treatment.
Alternatively, the use of indocyanine green
fluorescence cholangiography (ICG-C) [62] as an
intravenous infusion before surgery can be a useful
technique to visualize the structures of the biliary tree,
particularly the cystic duct, without the need for X-ray
imaging. The usefulness of ICG-C to prevent BDIs has
been suggested in several studies and has also proven
useful for acute and chronic gallbladder diseases and in
those situations in which IOCs cannot be used [63–65].
Optimal timing of LC for acute cholecystitis
Systematic reviews analyzing data from RCTs [66] and
population-based studies [67, 68] showed higher BDI
rates in acute conditions, supporting the hypothesis of
increasing BDI risk with increasing severity of local in-
flammation, such as in the case of acute cholecystitis
(AC) [67]. Different time frames for operating on pa-
tients presenting with symptomatic AC have been pro-
posed, ranging from no more than 72 h up to 10 days.
Further delays are associated with disease progression,
and despite medical treatments, unfavorable conditions
for safe surgical interventions exist [39]. Indeed, an in-
crease in the complication rate and need of conversion
to open cholecystectomy has been reported when the
time from symptom appearance to surgery was pro-
longed [69–71], with the latest timepoint to safely oper-
ate on AC patients being 10 days from symptoms
appearance [39].
Q2. What are the reported BDI rates during LC in emergency and
elective settings and when should a surgical team review its
current practice to improve the standards of care?
Statement:
2.1. Based on large nationwide databases and systematic review of the
literature, major BDIs occur in 0.1% of elective LC and 0.3% of
emergency LC. If considering all types of BDIs, rates are 0.4% and 0.8%
for elective and emergency settings, respectively. When a surgical team
experiences an increased rate of BDIs, a careful review of the current
practice is mandatory to critically analyze the possible causes and
implement educational, training, and technical solutions to improve the
standards of care.
Strong recommendation, low quality of evidence (GRADE 1C)
Literature review
Given the number of LCs performed worldwide,
thousands of patients per year will experience BDIs with
severe and long-term implications for their health.
Moreover, BDIs can have a substantial impact on the
surgeon’s mental status and reputation and can
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constitute a non-negligible financial burden for health-
care systems [11].
The goal of any general surgery unit should ideally be
a 0% BDI rate, but this is rarely observed in real-life
practice. A nationwide database and worldwide experi-
ence are necessary to describe the overall incidence of
BDIs in elective and emergency settings. Whenever in-
creased rates are experienced locally, the surgical team
should carefully review the current practice, critically
analyze the possible causes, and implement educational,
training, and technical solutions to improve the stan-
dards of care.
Epidemiological data are useful for clinicians,
surgeons, and healthcare systems to measure surgical
outcomes and performance (for monitoring or audit
purposes); for patients to weigh the surgical risks; and
for researchers to compare and interpret their findings
[24]. However, assessing the true frequency of BDIs
remains challenging. The main problem is related to the
sample size needed to observe BDIs and eventually
detect significant changes over time [72].
A systematic literature search limited to articles
published between 2011 and 2020 identified 16 studies
analyzing 14 different databases from 5 different
countries [12, 73–87]. The rates of BDIs during LC
differed significantly depending on the population
investigated, the criteria used in each study, and the
definition of BDI.
Based on the Swedish National Quality Registry of
Gallstone Surgery and Endoscopic Retrograde
Cholangiopancreatography (GallRiks) established in
2005, Tornqvist et al .[78] analyzed 51,041
cholecystectomies and reported an overall BDI rate of
1.5% according to the Hannover classification system,
which includes bile duct leaks [17]. The BDI rates
during LC and open cholecystectomy were 1.3% and
2.8%, respectively. AC and emergency admissions were
associated with BDI rates of 1.9% and 1.8%, respectively.
A more recent article by Pucher et al. provided an
extensive literature review of 151 studies accounting for
a total of 505,292 patients undergoing LC [87]. The
authors selected only studies including at least 100
patients and excluded those explicitly describing early
case experiences or learning curves to ensure
representativeness of an established surgical practice.
Pooled data analyses (based on 70% of the included
studies corresponding to 60% of patients) showed an
overall BDI rate ranging from 0.32 to 0.52%. Sixty-five
studies differentiated between major and minor injuries
and showed a prevalence of 0.28% for major injuries and
0.46% for bile leaks (overall 0.74%) [87].
Several studies defined BDI as the need for further
reconstructive surgery (i.e., bilioenteric anastomosis),
and they reported a reconstructive surgery rate range
between 0.04 and 0.3% [73–77]. When considering only
the need for any type of surgical repair of the common
bile duct, the rate ranged between 0.06% and 0.31% [73,
76, 82, 83, 85, 88].
The California Cholecystectomy Group analyzed
711,454 cholecystectomies (of which 95% were LCs)
from the California Office of Statewide Health
Planning and Development (COSHPD) database from
2005 to 2014. They found a bile leak rate of 0.5%, defined
by the need for isolated endoscopic retrograde
cholangiopancreatography (ERCP) or percutaneous
transhepatic cholangiography (PTC) within 4 weeks after
cholecystectomy [12]. Patients who underwent
choledocho-enterostomy, common bile duct suture,
hepatectomy, liver transplantation, more than 1 ERCP
within a year, or 1 or more PTCs between 4 weeks
and 1 year were considered to have a BDI. The rate
of these major BDIs was 0.22%, and together, they
accounted for 0.72% of patients requiring any ERCP,
PTC, or surgical procedure after LC [12].
A higher incidence of BDIs can be expected in cases of
inflammation (acute or chronic) [75, 78–80] or
emergency cholecystectomy [75, 78, 79]. Based on the
GallRiks database, patients with AC at the time of
surgery or with a positive history of AC are at higher
risk of BDI (odds ratios, ORs: 1.23 and 1.34,
respectively), which can be reduced by performing IOC
[78]. Mangieri et al. analyzed 217,774 LCs in the NSQIP
database, 67% of which presented with AC. They found
a small yet significantly higher incidence rate of BDIs in
AC (0.21% vs. 0.18%) [84]. In a nationwide study of 572,
223 LCs conducted in England, only a very small
difference was reported concerning the need for
reconstructive biliary surgery between patients
presenting with AC on admission and patients operated
on in the elective setting (0.09% vs. 0.11%) [74]. Other
studies found no differences in biliary adverse events
between LC patients with or without AC [66, 87, 89] or
between elective and emergency procedures (0.3%) [81].
Q3. Which classifications of BDI should be adopted, and what is
the minimum required information that the surgeon must report
after diagnosing BDI during LC?
Statements:
3.1. We recommend knowing Strasberg’s classification, which remains
the most commonly used classification for BDIs, and the ATOM
classification, which represents the most recent and complete
classification; the implementation of the ATOM classification should be
promoted in the near future.
Strong recommendation, low quality of evidence (GRADE 1C)
3.2. The ideal operative report must maximize the amount of
intraoperative detail given to describe the BDI. The following should
minimally be included:
1. The clinical context and indication for cholecystectomy
2. Intraoperative findings
3. The anatomical landmarks of the critical view of safety [66, 73, 90]
4. Any anatomical variation of the biliary tract [88, 89]
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Literature review (Continued)
5. Cholangiography findings (if performed) [66, 81]
6. Operative data (e.g., operative time, blood loss, energy device used
for dissection, need for conversion)
7. Drawing of the BDI with biliary drain placement (if used)
8. Videotape of the procedure (whenever available).
Strong recommendation, low quality of evidence (GRADE 1C)
Literature review
An integrated description and diagnosis of BDI is
essential to choose the most appropriate management,
which depends on the time of detection, the extent of
bile duct and vascular injuries, and the underlying
mechanism. These aspects must be included in the
diagnostic assessment using an appropriate and specific
BDI classification.
Several BDI classifications have been proposed over
the years. They described different subtypes of injuries
according to their severity and have taken into account
the biliary tract anatomy or the level of the biliary injury;
alternatively, some integrated the possible associated
vascular injuries of the hepatic hilum into the
description of BDI [91]. To date, there is still no
consensus on a “gold standard” classification for BDIs,
but there are some widely adopted classification systems,
which are summarized in Table 2. Direct comparisons
among the available classification systems are also
difficult. Each classification has strengths and drawbacks,
as they all lack the standardization of a common
nomenclature.
How to classify BDI
Classification systems that are essentially based on the
biliary injury location include the first classification
published by Bismuth in 1982 [92, 93], followed by the
Strasberg’s one proposed in 1995 [90], and other
classification systems published by McMahon [94],
Bergman [95], Neuhaus [96], and Csendes [97].
Conversely, classification systems that integrate vascular
injuries into the description of BDIs are the Stewart-
Way classification published in 2007 [98], the Hannover
classification [17], the one proposed by Lau et al. [99],
and more recently the ATOM (Anatomic, Time Of de-
tection, Mechanism) classification published by the
European Association for Endoscopic Surgery (EAES) in
2013 [100]. The ATOM integrates the Bismuth, Stras-
berg, Neuhaus, McMahon, Connor, and Lau classifica-
tions into a composite, all-inclusive, nominal system
(Tables 2 and 3), which combines bile tract anatomical
damage, vascular injury, timing of detection, and mech-
anism of damage in an exhaustive classification system
covering all possible injuries. The EAES intended the
ATOM classification as a specific effort toward
standardization and transformation of BDI definitions
into a unified language. Moreover, the ATOM system
was thought to facilitate the collection of data for epi-
demiological and comparative studies, ultimately leading
to a more precise determination of the true incidence of
BDI incurred during LC and consequently favoring the
development of preventive measures [101]. The main
drawback is that it may be too complex and time-
consuming to be used in routine clinical practice.
Clinically, BDIs are often grouped into minor or major
injuries. Minor BDIs include injuries caused by
electrocautery burns or a partial cut from sharp
dissection with shears and are not associated with tissue
loss. These injuries can typically be repaired primarily
with sutures and placement of abdominal drains in the
area [102]. Conversely, major BDIs (i.e., Strasberg E) are
associated with tissue loss (e.g., the common bile duct is
clipped and transected) and require complex
reconstruction with a Roux-en-Y hepaticojejunostomy.
How to describe BDI
Once BDI has occurred and been recognized during LC
(approximately 25% of cases [99, 103]), a detailed and
precise surgical report will be critically important to
guide BDI management. The surgical report must
include the indication for the surgery, the patient’s
comorbidities, the operative time, the amount of blood
loss, the type of injury that occurred (in detail), and the
use of drainage.
The ideal report should follow the CVS schema
described by Strasberg in 1995 [90]. The CVS is
composed of three critical steps: (1) the visualization of
the hepatocystic triangle with no exposure of the
common bile duct; (2) the exposure of the lower part of
the gallbladder and its separation from the liver bed; and
(3) the visualization of only 2 structures that enter the
gallbladder: the cystic duct and the cystic artery. The
surgeon must report during which of the CVS steps
difficulties were encountered and BDI occurred.
Whether a timeout during LC, prior to transecting any
ductal structure, is performed should be reported.
Similarly, it is important to report whether another
surgeon was consulted at the time of the dissection or
during the difficult steps. Any anatomical abnormality or
unusual findings should be described, including:
– Bile drainage from a location other than the
gallbladder
– Bile draining from a tubular structure
– A second cystic artery or large artery posterior to
the cystic duct
– A short cystic duct
– A bile duct that can be traced to the duodenum
– Severe hemorrhage or inflammation.
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Whenever an intraoperative biliary tract imaging
technique (IOC or ICG-C [104]) is performed,
these findings must also be reported, and cholangi-
ography images should be included in the report
[105, 106].
Particularly, the following should be specified:
– Failure to opacify the proximal hepatic duct or the
cystic duct
– Identification of an extra bile duct, an aberrant bile
duct, or duct of Luschka
– Ductal abnormalities: wide cystic duct (which may
be the common bile duct), accessory bile duct,
second cystic duct (which may be the common
hepatic duct), and abnormal gallbladder
infundibulum that may indicate that the common
bile duct was dissected.
If possible, a drawing of the BDI with biliary drainage
positioning (if used) could be helpful. If a videotape of
the surgical procedure is available, it should be added to
the report [107–109].





















Cystic duct leak or leaks from small
ducts in liver bed
A A Type I Type A Type 1 NMBD
Occlusion of an aberrant RHD B Type 2
Leak from an aberrant RHD C
Lateral injury to CBD < 50%
diameter
D Type 2
Laceration > 25% of CBD Major bile
duct injury
B
Transection of CBD or CHD Major bile
duct injury
D Type III Class II/III Type D Type 3
Resection od more than 10 mm of
the CBD
Type IV
Tangential injury of the CBD Type C
Right/left hepatic duct or sectoral
duct injuries
Type 4
Laceration < 25% of CBD Minor bile
duct injury
Class I




Stenosis of the main bile duct
without injury (caused by a clip)
Type B
CBD stump > 2 cm Type I EI MBD 1
CBD stump < 2 cm Type II E2 MBD 2
Ceiling of the biliary confluence is
intact
Type III E3 MBD 3
Ceiling of the confluence is
destroyed
Type IV E4 MBD 4
Type I, II or III + stricture of an
isolated right duct
Type V E5






Right hepatic artery + RHD
transected
Class IV Type D Type 5 VBI+
RHD right hepatic duct, CBD common bile duct, CHD common hepatic duct, NMBD non-main bile duct, MBD main bile duct, VBI vasculobiliary injury
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Q4. What are the surgical management strategies and timing for
intraoperatively diagnosed BDI?
Statements:
4.1. We recommend the selective use of adjuncts for biliary tract
visualization (e.g., IOC, ICG-C) during difficult LC or whenever BDI is sus-
pected to increase the rate of intraoperative diagnosis. The opinion of
another surgeon should also be considered.
Weak recommendation, moderate quality of evidence (GRADE 2B)
4.2. Direct repair with or without T-tube placement may be considered
in cases of minor BDIs. Hepaticojejunostomy should be considered the
treatment of choice in cases of major BDIs.
Strong recommendation, low quality of evidence (GRADE 1C)
4.3. Early BDI repair (on-table up to 72 h) may be considered in cases of
appropriate surgical indications and expertise. Referral to an HPB center
should be considered if sufficient HPB expertise is not available locally.
Strong recommendation, low quality of evidence (GRADE 1C)
4.4. Systematic immediate repair of isolated injuries of the right hepatic
artery is not recommended, and the benefit/risk ratio should be
evaluated carefully.
Weak recommendation, very low quality of evidence (GRADE 2C)
4.5. The repair of complex injuries (e.g., vasculobiliary) should be delayed
and not attempted intraoperatively, even by expert HPB surgeons.
Weak recommendation, low quality of evidence (GRADE 2C)
Literature review
In the event of intraoperative recognition of BDI, the
subsequent management is highly dependent on the
injury extent and classification. The first key factor is the
timing of the intraoperative recognition of BDI: the
earlier the recognition, the better the outcomes [79].
Data from the nationwide GallRiks prospective registry
highlighted that patients with BDI have a significantly
poorer 1-year overall survival than non-injured patients
(1-year mortality: 3.9% vs. 1.1%, respectively). Particu-
larly, Cox regression analysis demonstrated that patients
who had injuries with delayed detection have almost a
doubled risk of mortality compared with patients who
had no injury (hazard ratio, HR: 1.95; 95% confidence
interval, CI: 1.12–3.37). Conversely, no difference in 1-
year survival rates was observed in patients with BDIs
detected perioperatively compared to those without a
BDI [78]. These data demonstrate that the timing of BDI
recognition matters; nevertheless, BDIs diagnosed intra-
operatively represent only a limited number of cases, al-
though the ranges reported in the literature are highly
variable (25–92%) [9, 79, 102, 110, 111].
To help in the intraoperative detection and
classification of BDI, several adjuncts can be used, such
as intraoperative ultrasonography (IOUS), IOC, and
ICG-C. Conversion to open surgery may be also consid-
ered in the event of BDI during LC [112, 113], with con-
version rates that vary from 23 to 71% [102, 114].
However, conversion to open surgery is not recom-
mended if the surgeon has sufficient experience in min-
imally invasive surgery to manage BDI laparoscopically.
Management of intraoperatively diagnosed BDI
The presence of an unexplained source of bile in the
operative field must raise the suspicion of a BDI. In
these cases, the use of IOC is helpful to detect BDI,
although it requires additional training and longer
operative times [7, 115]. A meta-analysis on 860 patients
showed that the selective versus the routine use of IOC
is associated with a comparable chance of detecting BDI
(odds ratio, OR: 0.36; 95% CI: 0.01–8.92; z = 0.63; p =
0.53) [116]. On the contrary, its use appeared to be help-
ful in terms of BDI risk reduction in patients with AC
(moderate or severe) [67, 78].
Table 3 ATOM classification [100]
Anatomical characteristics Time of detection Mechanism
Anatomic
level












Ep L Me ED
Occlusion Division









MBD main biliary duct, NMBD non main biliary duct (Luschka duct, aberrant duct, accessory duct), C complete, P, partial, LS, loss of substance, Me, mechanical, ED
energy driven, VBI vasculobiliary involvement, RHA right hepatic artery, LHA left hepatic artery, CHA common hepatic artery, PV portal vein, MV marginal vessels, Ei
early intraoperative, Ep early postoperative, L late, OC intra-operative cholangiogram
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IOUS could be useful to evaluate vascular injuries
associated with BDI and should be preferred to hilar
dissection during intraoperative staging to avoid further
damage [117].
ICG-C provides real-time imaging of the extrahepatic
biliary tract during LC and represents a noninvasive,
quick, safe, and easy-to-apply tool [64]. A recent meta-
analysis of 19 studies including 772 patients explored
the potential of ICG-C to identify biliary structures dur-
ing LC [118]. Four studies compared the use of ICG-C
to IOC in 215 patients and found no significant differ-
ences for cystic duct, common bile duct, or common
hepatic duct visualization. A recent survey involving
3411 surgeons (with an average of 16.1 years of practice)
highlighted how the use of adjuncts such IOC, ICG-C,
or intraoperative ultrasound, either routinely or select-
ively during difficult cholecystectomies, is not signifi-
cantly associated with a lower risk of BDIs [9]. It is
important to emphasize that factors such as geographic
distance between facilities, equipment, expertise, and lo-
gistics, vary significantly between institutions. Some au-
thors proposed that in cases of suspected BDI, asking
the opinion of another surgeon (physically or virtually)
may be an easy, effective, and inexpensive alternative to
IOC [119].
In the event of BDI detected during LC, surgeons
must promptly analyze the injury and choose between
an intraoperative repair or “drain now and fix later”
strategy [120]. For minor BDIs (i.e., Strasberg A–D and
conditionally E2), a direct repair, with or without the
placement of a T-tube, and the placement of abdominal
drains in the area is considered safe and appropriate
[121]. This strategy is reported in 5–58% of BDI cases in
the literature [102, 111, 122, 123].
If available on site, endoscopic decompression might
be considered in cases of Strasberg A injury [124].
However, the recur to this strategy is blunted by the
high rate of repair failure (up to 64%) [111].
For major BDIs (i.e., Strasberg E) associated with
tissue loss and whenever an ischemic injury is suspected,
a Roux-en-Y hepaticojejunostomy is the recommended
method of reconstruction [9, 111, 122, 125–128], with
the placement of a T-tube at a healthy region of the
common bile duct, either proximal or distal to the in-
jury, to decrease the incidence of future stricture forma-
tion [129]. Any dissection in the hilum may make
subsequent reconstruction more difficult or cause fur-
ther biliary or vascular injury. Thus, in case of insuffi-
cient experience in hepato-pancreato-biliary (HPB)
surgery, it is recommended to place a drain in the right
upper quadrant and transfer the patient to a center with
experienced HPB surgeons [129]. Conversion to an open
surgery to solely confirm diagnosis or perform injury
staging is not recommended.
A recent systematic review and meta-analysis [130]
considering 10 low-quality studies showed that on-table
repair (by direct suture or bilioenteric anastomosis) is
associated with a higher incidence, although non statisti-
cally significant, of failure than postoperative repair (60%
vs. 34.1%; OR: 2.06; 95% CI: 0.89–4.73; p = 0.09). More-
over, non-expert immediate repair attempts are associ-
ated with worse outcomes than expert repair potentially
compromising later revisions of the injury by a specialist
[130]. As supported by another single-center cohort
study on 200 patients with BDIs, on-table repair by non-
HPB specialists appears to be an independent risk factor
for recurrent cholangitis, biliary strictures, revision sur-
gery, and overall morbidity [126]. On the contrary, an
early referral to an HPB center can significantly decrease
the rate of postoperative complications (OR: 0.24; 95%
CI: 0.09–0.68; p = 0.007) and biliary strictures (OR: 0.28;
95% CI: 0.17–0.47; p < 0.001) compared to delayed refer-
ral [130]. Whenever a sufficient HPB experience is lo-
cally available, some data suggest that the earlier the
repair, the better the results [79, 102, 122, 126, 131],
whereas other studies support that similar and good out-
comes are to be expected for on-table / early (within 72
h [128]) repair vs. postoperative repair (within 1 week
[131]) when the BDI is managed by HPB surgeons or in
HPB referral centers [130].
However, it must be considered that in some countries
or regions, a tertiary/specialist care center may be too
distant, and the “traveling surgeon” practice may be
inappropriate [20, 127]. In these specific cases, it is of
utmost importance to assure an optimal local
management before referral, especially when, due to
logistic and geographical constraints, the time prior to
transport may be prolonged [20].
Management of concomitant vascular injuries
Because the hepatic blood supply is mainly carried by
the portal vein, the interruption of the right branch of
the hepatic artery alone is usually well tolerated [117,
132, 133]. Whenever an injury is recognized, the
immediate repair of the right hepatic artery is not the
most frequent option even in tertiary care centers, being
good results only occasionally reported (i.e., no
occurrence of liver infarction and uneventful follow-up)
[132, 133]. Indeed, opportunities for immediate arterial
repair are limited due to the low rate of injury recogni-
tion, the low number of patients affected by symptom-
atic liver ischemia, and the high level of technical
expertise required. Moreover, an extensive imaging
workup with a contrast-enhanced CT scan is mandatory
prior to attempting the vascular repair. Thus, given the
low clinical impact and the technical complexity of the
procedure, the efficacy of arterial reconstruction remains
questionable [132, 134].
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Vasculobiliary injuries, defined by the presence of both
biliary (bile duct obstruction or hilar plate division) and
vascular injuries (hepatic artery and/or portal vein
injury), lead to liver ischemia in 10% of cases [132, 133].
Their management depends on the evidence and extent
of the liver injury (e.g., ischemia, necrosis, or atrophy).
Their stabilization may require few weeks or months. In
general, the surgical management should be delayed to
allow for an accurate imaging workup and strategic
planning, which involves HPB surgeons.
A decision tree for the management of intraoperatively
detected BDIs is displayed in Fig. 1.
Q5. What is the recommended type and duration of antibiotic
regimen in cases of BDI?
Statements:
5.1. In cases of suspected BDI during elective LC without a history of
previous biliary drainage, antibiotic therapy may be considered using
broad-spectrum antibiotics.
Weak recommendation, very low quality of evidence (GRADE 2C)
5.2. In patients with previous biliary infection (i.e., cholecystitis,
cholangitis) and patients with preoperative endoscopic stenting, ENBD,
or PTBD at risk of developing local and systemic sepsis, broad-spectrum
antibiotics (4th-generation cephalosporins) are recommended, with fur-
ther adjustments according to antibiograms.
Strong recommendation, low quality of evidence (GRADE 1C)
5.3. In patients with biliary fistula, biloma, or bile peritonitis, antibiotics
should be started immediately (within 1 h) using piperacillin/
tazobactam, imipenem/cilastatin, meropenem, ertapenem, or aztreonam
associated with amikacin in cases of shock and using fluconazole in
fragile patients and cases of delayed diagnosis.
Strong recommendation, low quality of evidence (GRADE 1C)
5.4. In severe complicated intra-abdominal sepsis, open abdomen can
be considered an option for patients with organ failure and gross
contamination.
Weak recommendation, low and very low quality of evidence (GRADE 2C)
Literature review
To our knowledge, no study has specifically investigated
the indications, duration, and type of antibiotic therapy
in cases of BDI. In the absence of specific scientific data,
the following recommendations are adapted from
published literature and guidelines about the
management of biliary infections and abdominal sepsis
[135–142].
In general, depending on the timing of discovery and
presentation of BDI, consistent literature supports the
initiation of antibiotic therapy as a complement to
source control strategies in early or late identification of
BDIs. However, no consensus exists on the duration of
antibiotic treatment before or after gallbladder surgery
[143].
Antibiotic therapy in case of intraoperatively diagnosed BDI
In patients with previous biliary infections (e.g.,
cholecystitis, cholangitis) and patients with preoperative
instrumentation such as endoscopic stenting at ERCP/
sphincterotomy, endoscopic nasobiliary drainage
(ENBD), or percutaneous transhepatic biliary drainage/
cholangiography (PTBD/PTC), there may be preexisting
bactobilia. Consequently, bile flow into the peritoneal
cavity may lead to local or systemic sepsis. Thus,
intraoperative antibiotic coverage must be initiated or
continued in case an antibiotic prophylaxis has been
already administered. Bile culture is mandatory to
narrow the coverage spectrum and prevent antibiotic
resistance. Treatment should last no more than 24h
[136, 137]. The recommended antibiotics include
cefazolin, cefamandole, or cefuroxime (to be substituted
by gentamicin and clindamycin in case of allergy) [136,
137]. In case of infection and ongoing drainage, the
following antibiotics can be considered: piperacillin/
tazobactam, ceftriaxone, or other 4th-generation
Fig. 1 Decisional tree in case of intra-operatively detected BDI. N stands for no, Y for yes
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cephalosporins [144], for a minimum of 5 days of
treatment.
Antibiotic therapy in case of postcholecystectomy biliary
ductal stenosis
In the case of biliary obstruction without bile leak or signs of
sepsis, antibiotic therapy may not be required. However, the
majority of patients with biliary obstruction have infected
bile and grow bacteria from cultures even when clinical
cholangitis is not yet present. Sepsis may occur after biliary
instrumentation and drainage using endoscopic stenting,
ENBD, or PTBD. Antibiotic prophylaxis is appropriate and
recommended to prevent the occurrence of healthcare-
associated acute cholangitis, especially in the setting of pre-
dictable incomplete drainage [145].
Antibiotic therapy in case of biliary leakage
The first priority in case of bile leakage is “source control”
and early “goal-directed therapy” [140]. Antibiotic therapy
should be initiated as soon as evidence of cholangitis or
infected fluid collections appears [146]. In patients without
shock, radiological and bacteriological sampling can be
performed to obtain definitive diagnostic studies before
starting parenteral antibiotic therapy. A 6-h delay period
might be tolerated. In the presence of severe sepsis or shock,
the investigation window should be substantially shortened,
and broad-spectrum antibiotics should be started within 1 h
of the initiation of signs and symptoms. Treatment should
be adapted according to bile culture findings [136, 137]. In
the worst cases of severe complicated intra-abdominal sepsis,
open abdomen (OA) therapy for optimal source control may
be considered [147, 148], although the biological basis for
OA in such cases is currently being subjected to rigorous sci-
entific scrutiny [149].
In the case of external biliary fistula without
intraperitoneal collection, antimicrobial therapy might
not be necessary if infectious signs are absent. The
natural history of an external fistula depends on the
anatomical subtype of injuries. In complex BDIs
requiring delayed surgical repair, complete healing of the
fistula is an absolute prerequisite for surgery. During the
waiting period, several patients may experience
cholangitis. The Tokyo guidelines published in 2018 for
the severity grading and management of cholangitis may
be applicable [144]. Biliary drainage, most often using
PTBD, should be placed in cases of uncontrolled or
recurrent cholangitis. Parenteral broad-spectrum antibi-
otics should be started and subsequently adapted to bile
and blood cultures [150, 151]. Management of biloma
and peritonitis requires percutaneous drainage and sur-
gery, respectively. In the case of cholangiolytic abscesses,
which are usually small and multiple, parenteral antibi-
otics and biliary drainage (endoscopic or percutaneous)
may be indicated. A large cholangiolytic abscess not
responding to parenteral antibiotics within 48–72 h may
require imaging and US- or CT-guided percutaneous
needle aspiration or catheter drainage. The antibiotics
most often used in cases of biliary peritonitis are pipera-
cillin/tazobactam, imipenem/cilastatin, meropenem,
ertapenem, or aztreonam associated with amikacin in
cases of associated shock and fluconazole in cases of fra-
gility or delayed diagnosis.
The optimum duration of antibiotic therapy in the
setting of biliary infection is a matter of debate.
According to the Tokyo Guidelines [144], an additional
4 days of antibiotic therapy is required after source
control of cholangitis by decompression of the biliary
tree. Treatment should be continued for 2 weeks in the
presence of Enterococcus or Streptococcus to prevent the
risk of infectious endocarditis. Frailty and comorbid
factors must also be accounted for in the titration of
therapy. However, other studies showed that only 3
additional days are sufficient to reduce the risk of
recurrence [152, 153]. For biloma and generalized
peritonitis, a treatment of 5–7 days should be
considered [140].
Q6. Which are the clinical, biochemical, and imaging investigations
required for the postoperative diagnosis of BDI?
Statements:
6.1. We recommend a prompt investigation of patients who do not
rapidly recover after LC, with alarm symptoms being fever, abdominal
pain, distention, jaundice, nausea, and vomiting (depending on the type
of BDI).
Weak recommendation, low quality of evidence (GRADE 2C)
6.2. The assessment of liver function tests, including serum levels of
direct and indirect bilirubin, AST, ALT, ALP, GGT, and albumin, is
suggested in patients with clinical signs and symptoms suggestive of
BDI after LC. In critically ill patients, the serum levels of CRP, PCT, and
lactate may help in the evaluation of the severity of acute inflammation
and sepsis and in monitoring the response to treatment.
Weak recommendation, low quality of evidence (GRADE 2C)
6.3. Abdominal triphasic CT is suggested as the first-line diagnostic im-
aging investigation to detect intra-abdominal fluid collections and
ductal dilation. It may be complemented with the addition of CE-MRCP
to obtain the exact visualization, localization, and classification of BDI,
which is essential for planning a tailored treatment.
Weak recommendation, moderate quality of evidence (GRADE 2B)
Literature review
BDIs should be suspected and diagnosed as early as
possible in patients who do not promptly recover after
LC. The postoperative diagnosis of BDI is based on the
evaluation of signs and symptoms, laboratory tests, and
imaging studies.
Clinical signs and symptoms of BDI
The most frequent complaints of patients with BDI are
persistent abdominal pain, abdominal distension, nausea
and/or vomiting, fever, and jaundice [18]. The BDI
clinical presentations are related to the type of injury.
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The two most frequent clinical scenarios are bile leakage
and bile duct obstruction [154]. In patients with a bile
leak, an early visible sign is the presence of bile from the
drain or surgical incision. If the subhepatic region is not
drained, a perihepatic bile collection (biloma), abscess,
or biliary peritonitis may develop with corresponding
clinical signs. Generally, jaundice is not observed or is
mild in these cases because cholestasis does not occur
[18, 154–156]. In patients with biliary strictures,
symptoms are often delayed. Cholestatic jaundice with
choluria, fecal acholia, and pruritus are the most
common clinical signs and symptoms. If cholangitis
develops, fever with chills is typically associated with
jaundice [154–157]. Recurrent cholangitis is the main
consequence of bile duct stricture, hepatic injury and
dysfunction from complete bile duct occlusion. Sepsis
and multiorgan failure may develop in both clinical
settings.
When BDI is not identified intraoperatively or during
the first postoperative week, patients may have an
insidious evolution with relapsing abdominal pain,
cholangitis, and bile collections. A late diagnosis, which
sometimes is made years after surgery following multiple
ineffective attempted repairs or inappropriate
management, may result in increased complexity of bile
duct repair. Moreover, even if successfully managed, the
patient’s quality of life and survival may be impaired
[158]. Indeed, the clinical course of undiagnosed or
unrepaired BDI can evolve to secondary biliary cirrhosis
with portal hypertension, liver failure, and, ultimately,
death [18].
Biochemical tests for the diagnosis of BDI
After elective LC, laboratory tests are not routinely
required because mild to moderate elevations in
hepatocellular enzymes are frequently observed during
the postoperative period but have no pathological
meaning; CO2 pneumoperitoneum seems to be the main
reason for these changes [159, 160].
In clinical practice, surgeons should consider
postoperative biochemical investigations whenever
difficulties were encountered during the intervention or
in the presence of postoperative clinical signs suggestive
of complications. These are performed to aid in the
diagnosis [154, 157, 161]. Ben-Ishay et al. [161] evaluated
the utility of post-LC blood examinations by retrospect-
ively analyzing the chart data of approximately 340 pa-
tients undergoing LC and confirmed that they may be
useful to make diagnoses and lead to early interventions
in complicated cases. Blood tests were most often ob-
tained in elderly patients and those who had prolonged
surgery, multiple drains, and longer hospital stays.
Serum levels of direct and indirect bilirubin, aspartate
aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (ALP), gamma-glutamyl
transpeptidase (GGT), and albumin, as well as a
complete blood count (CBC), are usually measured to
diagnose iatrogenic BDI [154, 157]. In BDI patients, liver
function tests and cholestatic enzymes may either be ele-
vated, supporting the clinical suspicion, or remain within
the normal ranges. In the case of stenosis or complete
occlusion of the bile duct, bilirubin values increase,
whereas no elevation or only a slight elevation may be
observed as a result of peritoneal bile absorption in the
presence of bile leakage [99]. In the very early stages,
cholestasis markers are increased, but there is no signifi-
cant hepatic damage; therefore, aminotransferases are
not increased. Early in the initial postoperative course,
the determination of ALP and total bilirubin is not sen-
sitive [162].
Biomarkers, such as C-reactive protein (CRP), procal-
citonin (PCT), and serum lactate, can help to evaluate
the severity of the inflammation or sepsis and provide a
baseline to follow the therapeutic response [163, 164].
PCT, CRP, and lactate levels can also be used to predict
fatal progression in septic patients and are associated
with poor outcomes and increased mortality [163, 164].
Imaging for postoperative diagnosis of BDI
The role of imaging is to establish the BDI diagnosis,
delineate the type and extent of the injury, and plan the
appropriate intervention.
Ultrasonography (US) represents the primary
noninvasive and easily available diagnostic tool that
allows for the detection of intra-abdominal fluid collec-
tions, dilation of the biliary ducts, and possibly associ-
ated vascular lesions by using Doppler evaluation [154,
157, 165]. Abdominal triphasic CT scanning is useful to
identify the possible presence of focal intra- or perihepa-
tic fluid collections, ascites, biliary obstruction with up-
stream dilation, and long-term sequelae of a long-
standing bile stricture, such as lobar hepatic atrophy or
signs of secondary biliary cirrhosis. CT can also identify
associated vascular lesions, such as injury to the right
hepatic artery [154, 157]. The sensitivity of CT is super-
ior to that of US, especially for the detection of small
fluid collections and associated vascular complications
[166–168]. US provides good anatomic and contrast
resolution, but CT has higher spatial resolution and bet-
ter identification of fluid collection morphology and site;
CT is also essential to define collections that require
percutaneous or surgical drainage. However, neither US
nor CT examinations can reliably distinguish bile leaks
from other postoperative fluid collections, such as blood,
pus, or serous fluid, because of their similar densities.
Neither can establish the precise location or the active
state of a bile leak because the bile collection site may
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not be separate from the leak site and occasionally may
even be intrahepatic [169].
Hepatobiliary scintigraphy (HS) has two potential
advantages over US and CT. It seems to be more
sensitive and specific than US or CT in detecting bile
leaks [170], and in addition to confirming the presence
of a bile leak, it can identify the relationship between the
leak and any fluid collection as well as show the primary
route of bile flow [171]. Despite this, it is frequently
necessary to complete HS with additional investigations.
In fact, HS can provide functional information
demonstrating the presence of an active leak, but its
spatial resolution is poor, and the identification of the
leak site can be challenging [169, 172]. Other pitfalls of
HS are that extrabiliary structures are not visualized, so
no information about them can be obtained, it has poor
sensitivity in patients with hepatic dysfunction and large
bile duct defects with preferential bile flow in a path of
least resistance, and it may not show activity in the
duodenum and thus a bile leak may be misinterpreted as
a complete bile duct obstruction [169].
The use of ERCP and PTC can identify a continuing
bile leak, provide exact anatomical diagnosis, and allow,
at the same time, the treatment of the injury by
appropriately decompressing or dilating the biliary tree.
ERCP can be applied to treat bile leaks using internal
stents. Success using this technique may be more likely
if the injury to the duct is < 5 mm, if the injury is
extrahepatic, and when there is no associated abscess or
biloma [173]. In the case of ERCP failure, PTC is a valuable
option to accurately depict the location and nature of BDI
and to perform an extraluminal percutaneous endoscopic
rendezvous procedure with stent placement to restore
continuity of the bile duct [174–176].
On the other hand, ERCP and PTC are invasive
techniques that are associated with a nonnegligible risk
of complications, including severe acute pancreatitis
(mainly after ERCP), bleeding, and cholangitis (after
PTC) [177, 178]. Other disadvantages are the lack of
detection of extrabiliary abnormalities and the non-
visualization of ducts upstream or downstream from an
obstructing lesion (e.g., stricture, stone). Moreover, PTC
can be technically difficult because intrahepatic bile
ducts are usually not dilated [170].
Magnetic resonance cholangiopancreatography
(MRCP) represents the “gold standard” for a complete
morphological evaluation of the biliary tree, as it is
noninvasive, does not use ionizing radiation, and
provides excellent anatomical information regarding the
biliary tree anatomy proximal and distal to the level of
injury [154, 157, 169]. MRCP combined with dynamic
contrast-enhanced magnetic resonance using a
hepatocyte-selective contrast agent with biliary excretion
allows for the functional assessment of the biliary tree,
and thus, the detection and localization of bile leaks with
an accuracy close to 100% [179]. In the past, the use of
mangafodipir trisodium as a contrast agent primarily ex-
creted via bile — now withdrawn from the EU Market
— was shown to be useful for both diagnosing a bile leak
and identifying the source of the leak by direct
visualization of contrast material extravasation into fluid
collections [179, 180].
Several authors [181–185] confirmed that the
additional use of contrast-enhanced MRCP (CE-MRCP)
using 3D and 2D T1-weighted images acquired at the
hepatobiliary phase after hepato-specific contrast agent
injection improves the accuracy of bile anatomy depic-
tion and bile leak detection. In a series of 99 patients —
including 24 followed after cholecystectomy, 20 after
surgical reconstruction of traumatic BDI, and 16 after
hydatid cystectomy — the use of CE-MRCP increased
the sensitivity, specificity, and accuracy, with respective
ranges (depending on the bile leak etiology) of 76–82%,
100%, and 75–91% compared to 53–63%, 51–66%, and
55–63% observed with conventional MRCP [183]. The
optimal timing for hepatobiliary phase acquisitions with
CE-MRCP appears to range between 60 and 90 min
when looking for bile leaks [182, 186].
In the post-liver transplant setting, Boraschi et al.
[187] studied 384 MRCP examinations in 232 patients.
The reported sensitivity, specificity, positive predictive
value, and negative predictive value for the detection of
BDI were 99%, 96%, 99%, and 97%, respectively. One
considerable MRCP limitation is the poor opacification
of bile ducts in the presence of obstruction and unreli-
able depiction of the more peripheral intrahepatic bile
ducts [179].
Q7. What are the surgical management strategies and timing for
postoperatively diagnosed BDI?
Statements:
7.1. In the case of minor BDIs (e.g., Strasberg A–D), if a drain is placed
after surgery and a bile leak is noted, an observation period and non-
operative management during the first hours is an option. If no drain is
placed during surgery, percutaneous treatment of the collection with
drain placement can be useful.
Weak recommendation, low quality of the evidence (GRADE 2C)
7.2. For minor BDIs, if no improvements or worsening of symptoms
occurs during the clinical observation period after percutaneous drain
placement, endoscopic management (by ERCP with biliary
sphincterotomy and stent placement) becomes mandatory.
Strong recommendation, low quality of the evidence (GRADE 1C)
7.3. In major BDIs (e.g., Strasberg E1–E2) diagnosed in the immediate
postoperative period (within 72 h), we recommend referral to a center
with expertise in HPB procedures if that expertise is locally unavailable.
An urgent surgical repair with bilioenteric anastomosis Roux-en-Y hepa-
ticojejunostomy could then be performed.
Strong recommendation, low quality of the evidence (GRADE 1C)
7.4. In major BDIs diagnosed between 72 h and 3 weeks, we
recommend percutaneous drainage of the fluid collections whenever
present, targeted antibiotics, and nutritional support. During this period,
an ERCP (sphincterotomy with or without stent) can be considered to
reduce the pressure gradient in the biliary tree, and a PTBD could be
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Literature review (Continued)
useful for septic patients with a complete obstruction of the common
bile duct. After a minimum of 3 weeks, if the patient’s general
conditions allow and the acute or subacute situation is resolved (e.g.,
closure of the biliary fistula), Roux-en-Y hepaticojejunostomy should be
performed.
Weak recommendation, low quality of the evidence (GRADE 2C)
7.5. When major BDIs are recognized late after the index LC and there
are clinical manifestations of stricture, Roux-en-Y hepaticojejunostomy
should be performed.
Weak recommendation, low quality of the evidence (GRADE 2C)
7.6. When major BDIs present as diffuse biliary peritonitis, urgent
abdominal cavity lavage and drainage are required as the first step of
treatment to achieve infection source control.
Strong recommendation, low quality of the evidence (GRADE 1C)
Literature review
With the great majority of BDIs being detected and
diagnosed postoperatively [188, 189], the type of
management must be chosen based on multiple criteria,
including the complexity of the biliary injury, the
severity of clinical presentation, the patient’s fitness and
comorbidities, and the availability of a skilled surgeon
with expertise in HPB surgery. In all cases, a
multidisciplinary approach involving interventional
radiologists, gastroenterologists, and surgeons is
advocated [19, 190]. Figure 2 depicts a decision
flowchart for cases of postoperatively detected BDI.
Management of minor BDIs
Minor BDIs (e.g., Strasberg A-D [90, 92]) require a step-
up approach once diagnosed. Common symptoms (e.g.,
abdominal pain or distension, fever, nausea), when noted
in the postoperative period, may herald postoperative
complications. In the presence of bile leakage from the
drain, observation and non-operative management are
advisable during the first hours [191]. If no drain was
placed after surgery and imaging reveals a bile collection
with suspicion of minor BDI (such as a cystic duct leak
or duct of Luschka), percutaneous drainage of the collec-
tion may be the definitive treatment [126]. Several case
series have reported the feasibility of drainage under
endoscopic ultrasound guidance [192], but more data
are needed before this approach may be recommended
in this specific clinical situation.
If no improvements or worsening of symptoms occur,
endoscopic management becomes mandatory [126, 193].
The same is true for low output biliary fistulas (i.e., a
bile leak from the liver bed such as a Luschka’s duct)
[193–195]. Various endoscopic treatments (i.e. biliary
stenting, endoscopic biliary sphincterotomy, and
nasobiliary drainage) are highly effective to treat biliary
leaks, except in the case of transection of the common
bile duct or common hepatic duct. The time lapse
between biliary injury and endoscopic treatment does
not seem to significantly impact on the treatment
outcomes [196].
Role of ERCP in BDI management
ERCP is the key tool in BDIs management because it
allows the identification of the site of bile leak and, most
importantly, allows internal biliary drainage if the
diagnosis of minor BDI is confirmed. Moreover,
incidental diagnoses, such as choledocholithiasis or bile
duct stricture, may also be treated in a single procedure.
For this reason, ERCP is nowadays widely recommended
as first-line therapy for postoperative biliary leaks [197].
The reported success rate of ERCP in this situation
ranges between 87.1% and 100%, depending on the
grade and the location of the leak [198–204]. Bile leaks
are divided into categories: (1) low grade, where the leak
can only be identified after complete opacification of the
intrahepatic biliary system; and (2) high grade, where the
leak can be observed before intrahepatic opacification
Fig. 2 Decisional tree in case of post-operatively detected BDI. N stands for no
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[203]. Leaks that respond more favorably to endoscopic
treatment are those located at the end of a cystic duct
stump or from a duct of Luschka, usually associated
with low output [197].
The limits of the endoscopic diagnosis concern the
lack of visualization of aberrant or sectioned bile ducts
(i.e., an aberrant right hepatic biliary duct) and the
difficulty in visualization of intra-hepatic proximal leaks.
Endoscopic management should be preferred when there
is at least partially documented continuity of the BDI (at
the MRCP) or a very close proximity of the two biliary
stumps (the proximal and the distal stumps); these are
the conditions in which attempting endoscopic repair
with the multistenting strategy [205].
The main goal of endoscopic therapy is to reduce the
transpapillary pressure gradient to facilitate preferential
bile flow through the papilla as opposed to the site of
the leak, providing time to the biliary tree injury to heal.
This is most commonly achieved by placing a
transpapillary stent. Temporary naso-biliary drainage
showed a similar efficacy when compared to plastic
stents but has a lower patient compliance, so it should
not be considered as the first choice [206]. There is little
consensus on the role of sphincterotomy alone in the
management of these patients [207, 208]. Avoiding
sphincterotomy may minimize the risk for immediate
(e.g., bleeding or perforation) and long-term complica-
tions (e.g., cholangitis or pancreatitis) [209]. The most
frequent approach is the combination of biliary sphinc-
terotomy with the placement of plastic stents or fully/
partially covered metal stents, which is associated with a
high success rate in low-grade biliary leaks [126, 199,
202–204, 210, 211], and it is deemed even more effective
in cases of high-grade leaks [199–201, 203]. Although
less investigated in the literature, long-term (at 10 years)
outcomes of endoscopic treatment with stent placement
appeared to be good and effective in patients with post-
operative biliary strictures [212–214].
Plastic stents are recommended to be placed to treat
bile duct leaks [201]. For refractory bile leaks, fully
covered self-expanding metal stents were demonstrated
to be superior to multiple plastic stents in a non-
randomized trial [215]. Stents are left in place for ap-
proximately 4 to 8 weeks in many studies and removed
if retrograde cholangiography shows the resolution of
the leakage.
The first-line approach to benign biliary strictures
complicating cholecystectomy is endoscopic, as well.
When recognized early in the post-operative period,
strictures are often due to surgical trauma (e.g., energy
device) and associated with bile leak. These strictures re-
spond to endoscopic treatment more favorably than fi-
brotic strictures, which have a delayed diagnosis.
Temporary placement of multiple plastic stents over a
long period of time is the preferred treatment, with a
success rate ranging from 74 to 90%, but with a recur-
rence rate as high as 30% within 2 years from stent re-
moval [212, 216, 217]. In case of post-cholecystectomy
bile strictures located > 2 cm from the main hepatic
confluence, fully covered SEMS can be an alternative to
plastic stents [201].
When ERCP is unsuccessful or not feasible, PTBD
becomes an alternative. Moreover, PTBD can be useful
for septic patients with a complete obstruction of the
common bile duct as part of the multidisciplinary
approach when ERCP fails or when surgical repair
failures need to be treated (i.e., stricture of the
hepaticojejunostomy). PTBD in the presence of bile
leakage may be more difficult as a result of non-dilated
bile ducts but still leads to a technical success of 90%
and a short-term clinical success of 70–80% in expertise
centers [214, 218, 219].
Management of major BDIs
In the case of major BDIs (e.g., Strasberg E1–E5) in
which there is a complete loss of common and/or
hepatic bile duct continuity, carefully planned surgical
treatment is required. Even when an endoscopic
approach has been performed, high-grade bile leaks are
difficult to manage successfully [191] and represent an
independent risk factor for morbidity [199]. Early ag-
gressive surgical repair (performed within 48 h from
diagnosis) seems to guarantee good results, avoid the
onset of sepsis, and provide advantages in terms of re-
duced costs and rate of hospital readmissions [195, 220,
221]. On the other hand, after 48–72 h, while inflamma-
tion tends to decrease, the phase of proliferation and
healing begins and further complicates surgical repair. A
key point is the technical contribution of the surgeon
[126, 194, 222]: several studies have emphasized higher
rates of postoperative failure, morbidity, and mortality
when a primary surgeon without HPB expertise attempts
to repair the injury [53, 189, 223–225]. Accordingly, in
the case of a lack of HPB experience, referral to a ter-
tiary care center immediately after diagnosis is essential
to ensure early surgical repair with Roux-en-Y hepatico-
jejunostomy [90], which showed superior outcomes at 5
years compared to late repairs [126]. An end-to-end
anastomosis may be performed if the loss of continuity
makes it technically possible, but this approach is associ-
ated with increased failure rates [195, 226]. Regardless of
the technique used, tension-free bilioenteric anastomosis
with good mucosal apposition and vascularized ducts is
the mainstay of treatment [227]. Recently, robotic proce-
dures have been suggested due to enhanced
visualization, better tissue handling, and more precise
surgery [228]. In the presence of increased tissue fragil-
ity, the expertise of the HPB surgeon in the tertiary care
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center is likely to improve the final results and conse-
quently the long-term outcomes [194, 195, 229].
When BDIs are recognized during the early
postoperative period (within 2 weeks), persistent tissue
injury from ongoing inflammation and the absence of
bile duct dilatation appear to negatively influence the
results and often lead to late strictures [229]. When the
diagnosis is not immediate or logistic constraints limit
referral to a tertiary care center, the “drain now, fix
later” algorithm [120] with percutaneous drainage of the
biloma [193], targeted antibiotic therapy, and nutritional
support seems to be the best approach. After clinical
stabilization, delayed surgical treatment can be safely
performed [20]. When a major leak results in
progressive biliary peritonitis, urgent surgical
intervention is required with laparoscopic lavage of the
abdominal cavity and drain placement [229]. Once the
patient has been successfully stabilized, several weeks
(2–3 weeks) are usually required for the resolution of
the acute inflammatory phase. Accordingly, this time
will allow for lowering the risks associated with
extensive reconstructive surgery by reducing
inflammation and guaranteeing the assessment of the
extent of ischemic injury resulting from associated
vascular injuries (right hepatic artery lesions have been
recognized in 25% of BDIs) [111, 126, 133, 222, 229,
230]. Similarly, a 1-week delay in the diagnosis of major
BDIs suggests the need for a “timeout” of 2–3 months
before intervention [105]. Combined BDI and hepatic ar-
tery injuries further increase the morbidity and mortality
of BDIs and may necessitate an early referral to a spe-
cialized HPB center. Combined repair may avoid ische-
mic damage to the liver parenchyma and the risk of
leakage or stricture of the bilioenteric anastomosis.
When an injury is not promptly recognized, hepatic ne-
crosis, atrophy, or even abscess within the ischemic par-
enchyma may occur, which would ultimately require
liver resection with bilioenteric anastomosis [117, 231,
232]. Roux-en-Y bilioenteric anastomosis represents the
gold standard treatment for major BDIs and is ideally
performed during the immediate postoperative period
(within 72 h). However, late repair should be considered
after the resolution of acute or subacute situations and
the closure of a biliary fistula on dilated bile ducts. In-
deed, in these complicated clinical scenarios, mortality
and morbidity rates after late repair are significantly
lower than rates after immediate and early repair: 0.8%
vs. 2.8% vs. 2.2% and 14.3% vs. 39.2% vs. 28.7%, respect-
ively [111]. Furthermore, the need for a second proced-
ure, that is, failure of the first repair, appeared to be
higher after immediate and early repair than after late
repair: 56.7% vs. 40.7% vs. 6.8%, respectively [111, 233].
However, the E-AHPBA multicenter study showed, after
multivariate regression analyses, that the timing of
biliary reconstruction with hepaticojejunostomy does
not have any impact on severe postoperative complica-
tions, the need for reintervention, or liver-related mor-
tality, leaving advisable the choice of an individualized
treatment strategy after iatrogenic BDI [234].
Outcomes of BDI treatment
As described above, BDI diagnosis can be made early or
late during the postoperative period. We reviewed the
literature concerning the management of BDIs suspected
and diagnosed postoperatively, leaving aside the clinical
scenarios in which BDIs are diagnosed or suspected
years after the index surgery due to the presence of
biliary sequelae of unrecognized injuries [235]. These
scenarios are beyond the scope of the present WSES
recommendations, but it is important to emphasize that
the evaluation of BDI management and repair outcomes
should be pursued in the long term, since late
complications, such as post-cholecystectomy biliary
strictures, recurrent cholangitis, and secondary biliary
cirrhosis, may occur [236, 237].
Although the literature is mainly based on case series,
the treatment of BDIs is generally considered as
successful [214, 238–243]. In a series of 31 patients with
BDI (of which 83% were major BDIs) referred to be
treated in a tertiary care institution, surgical intervention
(i.e., duct-to-duct anastomosis or biliary-enteric recon-
struction) represented the most frequent treatment
followed by naso-biliary drainage, drainage-observation,
and endoscopic sphincterotomy with biliary stenting.
The overall success rate was 83.3% in the early period;
however, 10 patients (32.3%) had late postoperative com-
plications (stricture and cholangitis), and of these, 3 re-
quired endoscopic stent placement, and 7 patients
underwent a biliary diversion with Roux-en-Y hepatico-
jejunostomy. Only one out of 24 patients with long-term
follow-up developed biliary cirrhosis, supporting satisfac-
tory long-term outcomes of BDI treatments [244].
Studies specifically investigating the long-term out-
comes of Roux-en-Y hepaticojejunostomy with biliary-
enteric anastomosis performed for major BDIs also sup-
port overall good outcomes [214, 239]. However, rele-
vant postoperative complication rates are reported.
Based on a recent review of the literature, the incidences
of anastomotic strictures vary between 4.1% and 69%,
with most studies reporting an incidence of 10–20%,
and a median time to stricture formation of 11-30
months. Associated vascular injury, level of BDI, sepsis
or peritonitis, and postoperative bile leakage have been
shown to be associated with worse outcomes [214]. The
reported incidences of biliary cirrhosis after BDI treat-
ment varies between 2.4% and 10.9 %[214]. Mortality
rate after BDI is also considerable: BDI-related mortality
varies between 1.8% and 4.6%, with some evidence
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Table 4 Summary of the consensus statements on BDI detection and management
Topic Statements Grade
Minimize the risk of BDI during LC 1.1. The use of the CVS during LC (achieving all 3 components) is the recommended
approach to minimize the risk of BDIs.
1C
1.2. If the CVS is not achievable during a difficult LC, a bailout procedure, such as STC,
should be considered.
1B
1.3. Conversion to open surgery may be considered during a difficult LC whenever the
operating surgeon cannot manage the procedure laparoscopically. However, there is
insufficient evidence to support conversion to open surgery as a strategy to avoid or reduce
the risk of BDI in difficult LCs.
2B
1.4. Intraoperative IOC is useful to recognize bile duct anatomy and choledocholithiasis in
cases of intraoperative suspicion of BDI, misunderstanding of biliary anatomy, or inability to
see the CVS, but routine use to reduce the BDI rate is not yet recommended.
2A
1.5. Intraoperative ICG-C is a promising noninvasive tool to recognize bile duct anatomy
and vascular structures, but routine use to reduce the BDI rate is not yet recommended.
2C
1.6. In patients presenting with AC, the optimal timing for LC is within 48 h, and no more
than 10 days from symptom appearance.
1A
1.7. In patients with at-risk conditions (e.g., scleroatrophic cholecystitis, Mirizzi syndrome),
an exhaustive preoperative work-up prior cholecystectomy is mandatory in order to discuss
and balance the risks/benefits ratio of the procedure.
2C
BDI rates and review of current practice
in general surgery unit
2.1. Based on large nationwide databases and systematic reviews of the literature, major BDIs
occur in 0.1% of elective LC and 0.3% of emergency LC. If considering all types of BDIs, rates
are 0.4% and 0.8% for elective and emergency settings, respectively. When a surgical team
experiences an increased rate of BDIs, a careful review of the current practice is mandatory to
critically analyze the possible causes and implement educational, training, and technical




3.1. We recommend knowing Strasberg’s classification, which remains the most commonly
used classification for BDIs, and the ATOM classification, which represents the most recent
and complete classification; the implementation of the ATOM classification should be
promoted in the near future.
1C
3.2. The ideal operative report must maximize the amount of intraoperative detail given to
describe the BDI. The following should minimally be included:
- The clinical context and indication for cholecystectomy
- Intraoperative findings
- The anatomical landmarks of the CVS
- Any anatomical variation of the biliary tract
- Cholangiography findings (if performed)
- Operative data (e.g., operative time, blood loss, energy device used, need for conversion)
- Drawing of the BDI with biliary drain placement (if used)




4.1. We recommend the selective use of adjuncts for biliary tract visualization (e.g., IOC, ICG-C)
during difficult LC or whenever BDI is suspected to increase the rate of intraoperative diagno-
sis. The opinion of another surgeon should also be considered.
2B
4.2. Direct repair with or without T-tube placement may be considered in cases of minor
BDIs. Hepaticojejunostomy should be considered as the treatment of choice in cases of major
BDIs.
1C
4.3. Early BDI repair (on-table up to 72 h) may be considered in cases of appropriate
surgical indications and expertise. Referral to an HPB center should be considered if sufficient
HPB expertise is not available locally.
1C
4.4. Systematic immediate repair of isolated injuries of the right hepatic artery is not
recommended, and the benefit/risk ratio should be evaluated carefully.
2C
4.5. The repair of complex injuries (e.g., vasculo-biliary) should be delayed and not
attempted intraoperatively even by expert HPB surgeons.
2C
Antibiotic regimen 5.1. In cases of suspected BDI during elective LC without a history of previous biliary drainage,
antibiotic therapy may be considered using broad-spectrum antibiotics.
2C
5.2. In patients with previous biliary infection (i.e., cholecystitis, cholangitis) and patients with
preoperative endoscopic stenting, ENBD, or PTBD at risk of developing local and systemic
sepsis, broad-spectrum antibiotics (4th-generation cephalosporins) are recommended, with
further adjustments according to antibiograms.
1C
5.3. In patients with biliary fistula, biloma, or bile peritonitis antibiotics should be started
immediately (within 1 h) using piperacillin/tazobactam, imipenem/cilastatin, meropenem,
1C
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supporting an increased mortality of 8.8% in BDI patients
compared to the expected age-adjusted death rate after 20
years [245]. Finally, most studies suggest that BDIs have a
detrimental impact on health-related quality of life when
compared to patients undergoing uneventful cholecystec-
tomy. Impaired quality of life, particularly in terms of
work-related limitations, loss of productivity, and in-
creased use of disability benefits, has been reported even
years after BDI treatment [214]. Thus, the best manage-
ment strategy will be identified as the one associated with
the more stable and predictable results over the follow-up.
Medicolegal aspects
In Europe, approximately 19-32% of patients with BDIs
are involved in a litigation claim, which translates into
medical liability of the operating surgeon and/or signifi-
cant payouts [214, 246]. These may represent a further
argument to support the management of most BDIs in
tertiary expert centers. Moreover, these data highlight
the importance of peroperative informed consent, in
which the possibility of severe complications, like BDI, is
adequately explained to the patient. Straightforward and
honest communication once the BDI has occurred and
detected is also crucial.
In this perspective, we suggest implementing a
“synoptic surgery reporting,” which represents a
standardized reporting of data fundamental to tracking
variations in care, evaluating the quality of care, and
finally, improving patient outcomes and cost-effective
treatments [247].
Conclusions
LC is one of the most common operations a general
surgeon performs in elective and emergency settings
Table 4 Summary of the consensus statements on BDI detection and management (Continued)
Topic Statements Grade
ertapenem, or aztreonam associated with amikacin in case of shock, and using fluconazole in
cases of fragile patients or delayed diagnosis.
5.4. In severe complicated intra-abdominal sepsis, open abdomen can be considered as an
option for patients with organ failure and gross contamination.
2C
Clinical, biochemical, and imaging
investigations for suspected BDI
6.1. We recommend a prompt investigation of patients who do not rapidly recover after LC,
with alarm symptoms being fever, abdominal pain, distention, jaundice, nausea and vomiting
(depending on the type of BDI).
2C
6.2. The assessment of liver function tests, including serum levels of direct and indirect
bilirubin, AST, ALT, ALP, GGT, and albumin, is suggested in patients with clinical signs and
symptoms suggestive of BDI after LC. In critically ill patients, the serum levels of CRP, PCT, and
lactate may help in the evaluation of the severity of acute inflammation and sepsis and in
monitoring the response to treatment.
2C
6.3. Abdominal triphasic CT is suggested as the first-line diagnostic imaging investigation
to detect intra-abdominal fluid collections and ductal dilation. It may be complemented with
the addition of CE-MRCP to obtain the exact visualization, localization and classification of




7.1. In the case of minor BDIs (e.g., Strasberg A-D), if a drain is placed after surgery and a bile
leak is noted, an observation period and nonoperative management during the first hours is
an option. If no drain is placed during surgery, the percutaneous treatment of the collection
with drain placement can be useful.
2C
7.2. For minor BDIs, if no improvements or worsening of symptoms occurs during the
clinical observation period after percutaneous drain placement, endoscopic management (by
ERCP with biliary sphincterotomy and stent placement) becomes mandatory.
1C
7.3. In major BDIs (e.g., Strasberg E1–E2) diagnosed in the immediate postoperative period
(within 72 h), we recommend referral to a center with expertise in HPB procedures, if that
expertise is locally unavailable. An urgent surgical repair with bilioenteric anastomosis Roux-
en-Y hepaticojejunostomy could then be performed.
1C
7.4. In major BDIs diagnosed between 72 h and 3 weeks, we recommend percutaneous
drainage of the fluid collections whenever present, targeted antibiotics, and nutritional
support. During this period, an ERCP (sphincterotomy with or without stent) can be
considered to reduce the pressure gradient in the biliary tree and a PTBD could be useful for
septic patients with a complete obstruction of the common bile duct. After a minimum of 3
weeks, if the patient’s general conditions allow and the acute or subacute situation is
resolved (e.g., closure of the biliary fistula), the Roux-en-Y hepaticojejunostomy should be
performed.
2C
7.5. When major BDIs are recognized late after the index LC and there are clinical
manifestations of stricture, Roux-en-Y hepaticojejunostomy should be performed.
2C
7.6. When major BDIs present as diffuse biliary peritonitis, urgent abdominal cavity lavage
and drainage are required as first step of treatment to achieve infection source control.
1C
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worldwide. BDI during LC is a severe complication that
requires prompt diagnosis and specific treatment to
avoid further morbidity and mortality. Practice
guidelines have been proposed to prevent BDIs during
LC [5], whereas BDI detection, classification, and
management, once they occur, remain basically
unstandardized. It is critical to have a plan if an injury is
detected intraoperatively and to follow a standardized
protocol in case of delayed diagnosis during the
postoperative period. The present guidelines offer a
thorough overview of the current literature about the
key aspects of BDI detection and treatment strategies in
various clinical situations. They are the results of
international and multidisciplinary work promoted by
the World Society of Emergency Surgery culminating in
a consensus conference where all proposed statements
and recommendations were approved by the worldwide
contributing experts (a summary of all statements and
recommendations is provided in Table 4). We must
acknowledge that, despite the large number of
publications on the topic, evidence was often derived from
retrospective, moderate- to low-quality studies. However,
the broad consensus reached by the expert panel allowed
proposing recommendations in most cases.
The present WSES guidelines contribute to clarifying
the complex decision-making process that the surgeon
has to face once a BDI is suspected, detected, and diag-
nosed. BDI management requires not only clinical know-
ledge and surgical skills but also a sensible evaluation of
the availability of local resources and the experience of
the medical team in terms of HPB surgery. Better patient
outcomes, with decreased morbidity and long-term com-
plications, are expected when BDIs are addressed at
high-volume centers by experienced multidisciplinary
teams. However, efforts should be made to guarantee
the best treatment options for any patient experiencing
BDI, irrespective of the hospital, country, or geograph-
ical inequalities; this could be achieved by the progres-
sive implementation of the present guidelines in clinical
practice to standardize BDI detection and management
among surgeons and clinicians worldwide.
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